2025 healthcare M&A outlook: What's driving high-value deals
Despite persistent inflation and labor challenges in 2024, healthcare M&A deal value grew to $69 billion — a $6 billion increase from the previous year. While overall transaction volume declined, the rise in deal value signals a clear shift toward fewer, high-value deals rooted in long-term strategic value.
Investors, health systems and private equity firms are doubling down on AI, portfolio optimization and vertical integration to navigate financial pressures and unlock new growth opportunities. VMG Health's 2025 Healthcare M&A Report breaks down the key forces reshaping the market, offering critical insights to guide strategic decision-making in the years ahead.
Key learning points:
Investors, health systems and private equity firms are doubling down on AI, portfolio optimization and vertical integration to navigate financial pressures and unlock new growth opportunities. VMG Health's 2025 Healthcare M&A Report breaks down the key forces reshaping the market, offering critical insights to guide strategic decision-making in the years ahead.
Key learning points:
- How inflation and regulatory shifts are shaping M&A activity
- Strategies driving resilient, high-value deals
- Market outlook across 13 key healthcare verticals
Please fill out the form to download the whitepaper.